Central obesity may affect bone development in adolescents: association between abdominal obesity index ABSI and adolescent bone mineral density
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01600-w ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Rubing Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shenzhen Children's Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Bone Density, Obesity, Abdominal, Bone Development, Nutrition Surveys. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong High-level Hospital Construction Fund and Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Purpose
Previous studies have suggested that obesity defined by body mass index(BMI) is a protective factor for bone mineral density(BMD), but have overlooked the potential influence of different types of obesity. This study aims to evaluate the correlation between abdominal obesity index A Body Shape Index(ABSI) and adolescent bone density, and analyze the relationship between abdominal obesity and bone metabolism.
Methods
A total of 1557 adolescent participants were included in NHANES from 2007 to 2018. Calculate the ABSI using a specific formula that takes into account waist circumference and BMI. A weighted multiple linear regression model is used to evaluate the linear correlation between ABSI and BMD. Forest plots are used to analyze the correlations between subgroups, and cubic splines are limited to evaluate the nonlinear correlations and saturation effects between ABSI and BMD.
Results
After adjusting for confounding factors, there was a significant linear correlation ( P < 0.01) between ABSI and femoral BMD, both as a continuous variable and an ordered categorical variable. The restrictive cubic spline curve indicates a significant nonlinear correlation and saturation effect between adolescent ABSI and BMD.
Conclusion
Research has shown a significant negative correlation between ABSI and BMD at the four detection sites of the femur, and this correlation may vary slightly due to age, race, family income, and different detection sites. The research results indicate that compared to overall body weight, fat distribution and content may be more closely related to bone metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
- Department of Spine Center, Medical School, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
- Department of Biological Sciences, Purdue University, West Lafayette, USA.
- Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, USA.
- Medical School of Chinese PLA, Beijing, China.
- Health Service Center of Baiyun Street, Jiaojiang District, Zhejiang, 318000, China. 404343631@qq.com.
Förderung
- Guangdong High-level Hospital Construction Fund and Sanming Project of Medicine in Shenzhen
Zitieren
APA
Lin, R., Tao, Y., Li, C., Li, F., Li, Z., Hong, X., & Liu, Y. (2024). Central obesity may affect bone development in adolescents: association between abdominal obesity index ABSI and adolescent bone mineral density. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01600-w
Vancouver
Lin R, Tao Y, Li C, Li F, Li Z, Hong X, et al. Central obesity may affect bone development in adolescents: association between abdominal obesity index ABSI and adolescent bone mineral density. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01600-w
BibTeX
@article{Lin2024,
author = {Lin, Rubing and Tao, Yuao and Li, Chuang and Li, Feifei and Li, Zijian and Hong, Xingyu and Liu, Yantong},
title = {Central obesity may affect bone development in adolescents: association between abdominal obesity index ABSI and adolescent bone mineral density},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01600-w}
}
EUVIMED